Delivery Order SPE2DR25D2006-SPE2DR26F56BD
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ferric Citrate 210 mg tablets (200-count units) valued at $13,976.72. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, with performance to be fulfilled from the awardee's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating AmerisourceBergen competed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ferric Citrate 210 mg tablets (200-count packages) with a contract value of $1,224.62. This non-set-aside, competitively awarded delivery order represents a firm fixed-price procurement scheduled for completion by April 25, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ferric Citrate 210 mg tablets in a quantity of 200 units, with a contract ceiling value of $4,653.89. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ferric Citrate 210 mg tablets (200-count units) with a ceiling value of $2,120.59. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 17, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this contract award. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ferric Citrate 210 mg tablets (200-count supply) on September 22, 2025, with a ceiling value of $1,498.00. This firm fixed price, non-competitive set-aside delivery order is scheduled for completion by September 23, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical supply transaction supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a $6,005.11 firm fixed price delivery order to AmerisourceBergen Drug Corp for 200 tablets of Ferric Citrate 210 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside award was competitively procured and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ferric citrate is an FDA-approved iron replacement therapy used to treat iron deficiency anemia in patients with chronic...
- The Defense Logistics Agency awarded a delivery order valued at $22,345.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of July 21, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Feraheme 510 mg/17 ml vials valued at $7,744.26 with firm fixed pricing. This non-set-aside competitive award is scheduled for completion by September 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,391.88 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials with a ceiling value of $2,321.19 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric iron supplement procurement supporting federal medical supply requirements. The contract was fulfilled by AmerisourceBergen's Corporate Office location in Conshohocken,...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56BDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Ferric Citrate 210 mg tablets (200-count) with a contract value of $4,316.52. The order will be completed by November 14, 2025, and operates under a firm fixed price structure with no set-aside designation. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering specialized pharmaceuticals across multiple therapeutic domains, from generic medications to brand-name drugs and vaccines. This delivery order for Ferric Citrate—an iron supplement used in the management of iron deficiency—exemplifies the company's role in supplying essential medications to support the Defense Health Agency and broader military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 11/13/25 |